✦ LIBER ✦

Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: a prospective study

✍ Scribed by Guglielmo Borgia; Ivan Gentile; Giuliana Fortunato; Francesco Borrelli; Salvatore Borelli; Maurizio De Caterina; Maria Donata Di Taranto; Maria Simone; Federico Borgia; Chiara Viola; Laura Reynaud; Raimondo Cerini; Lucia Sacchetti

Book ID: 111237973
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 94 KB
Volume: 29
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2008.01832.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated α-interferon-2a plus ribavirin

Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

✍ Amparo Escudero; Felicidad Rodríguez; Miguel A Serra; Juan A Del Olmo; Francisco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

1169 GENETIC POLYMORPHISM IN IL28B PREDI

1169 GENETIC POLYMORPHISM IN IL28B PREDICTS NULL VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C

✍ Kurosaki, M.; Tanaka, Y.; Nishida, N.; Sugiyama, M.; Matsuura, K.; Asahina, Y.; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Hepatocellular carcinoma in a long-term

Hepatocellular carcinoma in a long-term sustained virological responder following pegylated-interferon plus ribavirin combination therapy for chronic hepatitis C

✍ Gunal, E.; Celen, M.K. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Serum PAI-1 is a novel predictor for res

Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection

✍ D. Miki; W. Ohishi; H. Ochi; C. N. Hayes; H. Abe; M. Tsuge; M. Imamura; N. Kamat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

2′-,5′-Oligoadenylate synthetase respons

2′-,5′-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C

✍ K.-I. Kim; S.-R. Kim; N. Sasase; M. Taniguchi; S. Harada; K. Kinoshita; S.-H. Ki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB